ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$5.69
Tradestie Score
57
Market Cap
$202.58M
Revenue Growth
0.4%
Analyst Upside
+75.7%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$43.78
|
$824.20M | - | 57 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$4.48
|
$821.84M | - | 46 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$60.28
|
$800.41M | - | 55 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$5.48
|
$799.70M | - | 55 | Compare |
|
KURA
Kura Oncology, Inc.
|
$10.89
|
$798.53M | - | 52 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.42
|
$791.82M | - | 49 | Compare |
|
ANL
ANL
|
$13.00
|
$771.49M | - | 52 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$11.59
|
$757.72M | - | 45 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$28.26
|
$748.90M | - | 58 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.84
|
$726.21M | 7.6 | 53 | Compare |
More ACRS Analysis
Data updated: Jul 21, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry